GlassScriptPhysician profile
Mark S Crago
NPI 1093791410
$13,641.22
in general payments reported to CMS, 2019-2025
57 companies · $2,574 in 2025
The $2,574 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,468 · 2020: $966 · 2021: $1,724 · 2022: $2,605 · 2023: $2,331 · 2024: $1,973 · 2025: $2,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,854 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,854.11 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,438.07 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $1,417.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $807.67 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Janssen Pharmaceuticals, INC | $790.34 | 2019-2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $637.38 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $610.03 | 2022 | |
| Abbvie INC. | $582.02 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $569.43 | 2019-2025 | Otezla, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $514.49 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $503.95 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $492.77 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.26 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $392.55 | 2019-2024 | Veozah, Myrbetriq |
| Abbott Laboratories | $383.94 | 2020-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $375.64 | 2019-2025 | Shingrix, Arexvy, Boostrix |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $267.36 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Amarin Pharma, INC. | $222.95 | 2019-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $212.16 | 2024-2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $160.15 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $156.97 | 2019-2025 | Trintellix |
| Xeris Pharmaceuticals, INC. | $138.56 | 2023-2025 | Gvoke Hypopen, Keveyis |
| Esperion Therapeutics, INC. | $130.44 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $106.53 | 2022-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $96.85 | 2025 | Wavewriter Alpha Prime 16 |
| Sanofi-Aventis U.S. LLC | $83.81 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $83.43 | 2023-2025 | Voquezna |
| Eisai INC. | $65.53 | 2020-2021 | |
| Inspire Medical Systems, INC. | $65.09 | 2023-2025 | Inspire |
| Corcept Therapeutics | $60.24 | 2023-2025 | Korlym |
| Antares Pharma, INC. | $52.54 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Evoke Pharma, INC. | $50.44 | 2023 | Gimoti |
| Medtronic, INC. | $45.27 | 2024 | Kyphon Express II Kyphopak Tray |
| Exact Sciences Corporation | $43.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Optinose US, INC. | $43.26 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $43.25 | 2023-2024 | Rexulti |
| Sumitomo Pharma America, INC. | $40.89 | 2025 | Gemtesa |
| Genentech USA, INC. | $38.64 | 2019-2020 | |
| Lundbeck LLC | $38.14 | 2021-2024 | Rexulti |
| Nevro Corp. | $38.01 | 2021-2023 | Senza |
| Horizon Therapeutics Plc | $31.02 | 2023 | Krystexxa |
| Teva Pharmaceuticals USA, INC. | $28.07 | 2020 | |
| Allergan, INC. | $26.19 | 2020 | |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| Verona Pharma, INC. | $23.85 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $22.84 | 2021 | |
| Corium, LLC | $22.68 | 2023 | Azstarys |
| Irhythm Technologies, INC. | $20.47 | 2024 | Zio Monitor, Zio Xt Patch |
| Insulet Corporation | $19.82 | 2024 | Omnipod |
| Upsher-Smith Laboratories LLC | $18.94 | 2021 | |
| Dexcom, INC. | $17.04 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $17.00 | 2023 | Accrufer |
| Halozyme INC | $15.45 | 2023 | |
| Viatris Specialty LLC | $15.14 | 2025 | Yupelri |
| Saluda Medical Americas, INC. | $14.69 | 2025 | Evoke |
| Arbor Pharmaceuticals, INC. | $13.46 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.11 | 2023 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Crago listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.